Published: Jan 03, 2026
•ID: 4400700
•123 PagesTyphoid Vaccine
Typhoid Vaccine Market - Global Share, Size & Changing Dynamics 2020-2033
Global Typhoid Vaccine Market is segmented by Application (Disease prevention, public health, travel medicine, immunization programs, hospitals), Type (Conjugate vaccines, polysaccharide vaccines, oral vaccines, pediatric vaccines, combination vaccines), and Geography (North America, LATAM, West Europe, Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA)
Report ID:
HTF4400700
Published:
CAGR:
12.20%
Market Size (2024):
$0.85 billion
Forecast (2033):
$2.10 billion
Pricing
Report Overview
Overview
The global Typhoid Vaccine market was valued at 0.85 billion in 2024 and is expected to grow at a 12.20% from 2024 to 2033. The Typhoid Vaccine, which includes goods that people buy for their own use, is essential to the world economy. These products are typically separated into two primary categories: non-durable goods (such as food, drinks, and personal care items) and durable goods (such as furniture and appliances). Due to ongoing innovation and changing consumer preferences, the industry is fiercely competitive.
A typhoid vaccine is a biological preparation used to prevent typhoid fever caused by Salmonella typhi. It is administered orally or via injection and is essential for public health immunization programs and travel medicine.
Source: HTF Market Intelligence (HTF MI)
The research report shows the growth potential of the global Typhoid Vaccine market. The market for Typhoid Vaccine is anticipated to increase steadily. For Typhoid Vaccine to be widely used, supply chain optimization, cost reduction, and product differentiation are still essential. For market participants to take advantage of the enormous prospects offered by the Typhoid Vaccine market, they must make R&D investments, establish strategic alliances, and match their products with changing customer tastes.
Key highlights of the Study:
• CAGR of the market during the forecast period 2024-2033
• In-depth information on growth factors that will accelerate the Typhoid Vaccine market in the next few years.
• Detailed Insights on futuristic trends and changing consumer behavior in Typhoid Vaccine.
• Forecast of the Typhoid Vaccine market size and its contribution to the parent market by type, application, and region and country.
• A broad view of customer demand in the Typhoid Vaccine industry
• Uncover the market’s competitive landscape and in-depth information on various players
• Comprehensive information about factors that will challenge the growth of Typhoid Vaccine players.
Regional Analysis
- • Asia-Pacific and Africa highest demand; North America and Europe travel and public health use.
Market Entropy
- • Mar 2025 – VaxiSure Biologics supplied government immunization programs
Merger & Acquisition
- • Apr 2025 – A vaccine manufacturer acquired a typhoid vaccine developer to expand infectious disease portfolios.
Regulatory Landscape
- • Highly regulated under vaccine approval frameworks (FDA/EMA/WHO)
Patent Analysis
- • High patent density in conjugate formulations.
Investment and Funding Scenario
- • Strong public health funding
Typhoid Vaccine Market Dynamics
Numerous elements impact market dynamics in this industry, including evolving consumer preferences, legal requirements, and technological advancements.
Market Driver:
The report can identify and analyze the factors driving the growth of the Typhoid Vaccine market. Including
- • Endemic disease burden
The increasing demand for Typhoid Vaccine is one of the factors driving the market’s growth.
- • Conjugate vaccines adoption
Server factors driving the Typhoid Vaccine market’s opportunity.
- • Low-income regions
What challenges are facing the Typhoid Vaccine market?
- • Cold-chain logistics
Regional Outlook
The Asia-Pacific is experiencing the fastest growth, driven by its rapidly increasing population and expanding economic activity across key sectors. This acceleration is supported by growing urbanization, infrastructure development, and favorable government policies promoting industrial growth. Additionally, the region benefits from a youthful, expanding workforce and rising consumer demand. In contrast, Africa remains the market leader, maintaining its dominance through well-established industries, technological innovations, and a strong global presence.
- North America
- LATAM
- West Europe
- Central & Eastern Europe
- Northern Europe
- Southern Europe
- East Asia
- Southeast Asia
- South Asia
- Central Asia
- Oceania
- MEA
Loading map...
Typhoid Vaccine Key Players Covered
The companies profiled were selected based on insights from industry experts and a thorough evaluation of their market influence, product range, and geographical presence.
- • Bharat Biotech (India); Sanofi (France); GSK (UK); Pfizer (USA); Emergent BioSolutions (USA); Serum Institute (India); Biological E (India); Valneva (France); Takeda (Japan); Panacea Biotec (India); Bio Farma (Indonesia); Sinovac (China); Incepta (Bangladesh); CNBG (China); KM Biologics (Japan)
Companies are increasingly focused on expanding their market share through strategic initiatives such as mergers, acquisitions, and green investments, particularly in underserved regions. These strategies are helping companies capture a larger market share while fostering sustainable development. By consolidating resources and widening their geographical reach, these companies not only enhance their competitive position but also align with global trends in sustainability and corporate responsibility.
Typhoid Vaccine Market Segment Highlights
Segmentation by Type
- • Conjugate vaccines
- • polysaccharide vaccines
- • oral vaccines
- • pediatric vaccines
- • combination vaccines
Segmentation by Application
- • Disease prevention
- • public health
- • travel medicine
- • immunization programs
- • hospitals
This report also analyzes the market by region, providing insights into geographical differences in market performance.
- North America
- LATAM
- West Europe
- Central & Eastern Europe
- Northern Europe
- Southern Europe
- East Asia
- Southeast Asia
- South Asia
- Central Asia
- Oceania
- MEA
Get More Details on the Typhoid Vaccine Market Study
.
Need More Details on Market Players and Competitors?
Report Infographics
| Report Features | Details |
| Base Year | 2024 |
| Based Year Market Size 2024 | 0.85 billion |
| Historical Period | 2020 to 2024 |
| CAGR 2024 to 2033 | 12.20% |
| Forecast Period | 2026 to 2033 |
| Forecasted Period Market Size 2033 | 2.10 billion |
| Scope of the Report | Conjugate vaccines, polysaccharide vaccines, oral vaccines, pediatric vaccines, combination vaccines, Disease prevention, public health, travel medicine, immunization programs, hospitals |
| Companies Covered | Bharat Biotech (India); Sanofi (France); GSK (UK); Pfizer (USA); Emergent BioSolutions (USA); Serum Institute (India); Biological E (India); Valneva (France); Takeda (Japan); Panacea Biotec (India); Bio Farma (Indonesia); Sinovac (China); Incepta (Bangladesh); CNBG (China); KM Biologics (Japan) |
| Customization Scope | 15% Free Customization |
| Delivery Format | PDF and Excel through Email |